Basis of rabies virus neurovirulence in mice: Expression of major histocompatibility complex class I and class II mRNAs

Journal of NeuroVirology

Volumn 5, Issue 5, 1999, Pages 485-494

  Irwin, Darryl J ^a   Wunner, William H ^b   Ertl, Hildegund C J ^b   Jackson, Alan C ^a,c  

^a QUEEN S UNIVERSITY   (Canada)

^b WISTAR INSTITUTE   (United States)

^c KINGSTON GENERAL HOSPITAL   (Canada)

Author keywords

Gene expression; In situ hybridization; Pathogenesis; Rabies; Virulence

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; SULFUR 35;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BRAIN; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHOROID PLEXUS; CONTROLLED STUDY; EPENDYMA CELL; EPITHELIUM CELL; FEMALE; GLIA; HELPER CELL; IMMUNOPEROXIDASE STAINING; IN SITU HYBRIDIZATION; INFLAMMATION; INFLAMMATORY CELL; LYMPH NODE; MESSENGER RNA SYNTHESIS; MOUSE; NERVE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RABIES VIRUS; RNA PROBE; SPLEEN; STRAIN DIFFERENCE; T LYMPHOCYTE; VIRUS ENCEPHALITIS; VIRUS VIRULENCE;

ANIMALIA; RABIES VIRUS;

EID: 0032861099     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550289909045377     Document Type: Article

References (49)

1. Atkinson EA, Bleackley RC (1995). Mechanisms of lysis by cytotoxic T cells. Crit Rev Immunol 15: 359-384.
2. + T cells contribute to tissue destruction during Borna disease. J Immunol 153: 818-823.
3. Carson MJ, Reilly CR, Sutcliffe JG, Lo D (1998). Mature microglia resemble immature antigen-presenting cells. Glia 22: 72-85.
4. Coulon P, Derbin C, Kucera P, Lafay F, Prehaud C, Flamand A (1989). Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative Av01. J Virol 63: 3550-3554.
5. Dietzschold B, Wiktor TJ, Trojanowski JQ, Macfarlan RI, Wunner WH, Torres-Anjel MJ, Koprowski H (1985). Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J Virol 56: 12-18.
6. Dietzschold B, Wunner WH, Wiktor TJ, Lopes AD, Lafon M, Smith CL, Koprowski H (1983). Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 80: 70-74.
7. Duguid J, Trzepacz C (1993). Major histocompatibility complex genes have an increased brain expression after scrapie infection. Proc Natl Acad Sci USA 90: 114-117.
8. Ertl HCJ, Dietzschold B, Otvos L (1991). T helper cell epitope of rabies virus nucleoprotein defined by tri-and tetrapeptides. Eur J Immunol 21: 1-10
9. Flamand A, Coulon P, Pepin M, Blancou J, Rollin P, Portnoi D (1984). Immunogenic and protective power of avirulent mutants of rabies virus selected with neutralizing monoclonal antibodies. In: Modern Approaches to Vaccines: Molecular and Chemical Basis of Virus Virulence and Immunogenicity. Chanock RM, Lerner RA (eds). Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, pp 289-294.
10. Gogate N, Bakhiet M, Kristensson K, Norrby E, Olsson T (1991). Gamma interferon expression and major histocompatibility complex induction during measles and vesicular stomatitis virus infections of the brain. J Neuroimmunol 31: 19-26.
11. Gogate N, Swoveland P, Yamabe T, Verma L, Woyciechowska J, Tarnowskadziduszko E, Dymecki J, Dhib-Jalbut S (1996). Major histocompatibility complex class I expression on neurons in subacute sclerosing panencephalitis and experimental subacute measles encephalitis. J Neuropathol Exp Neurol 55: 435-443.
12. Gombold JL, Weiss SR (1992). Mouse hepatitis virus A59 increases steady-state levels of MHC mRNAs in primary glial cell cultures and in the murine central nervous system. Microbial Pathogen 13: 493-505
13. Guidotti LG, Chisari FV (1996). To kill or to cure: Options in host defense against viral infection. Curr Opin Immunol 8: 478-483
14. Hanlon CA, Ziemer EL, Hamir AN, Rupprecht CE (1989). Cerebrospinal fluid analysis of rabid and vacciniarabies glycoprotein recombinant, orally vaccinated raccoons (Procyon lotor). Am J Vet Res 50: 364-367.
15. Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B (1998). Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system. J Virol 72: 3711-3719
16. Jackson AC (1991). Biological basis of rabies virus neurovirulence in mice: comparative pathogenesis study using the immunoperoxidase technique. J Virol 65: 537-540.
17. Jackson AC (1994). Animal models of rabies virus neurovirulence. In: Current Topics in Microbiology and Immunology, Volume 187: Lyssaviruses. Rupprecht CE, Dietzschold B, Koprowski H (eds). Springer-Verlag, Berlin, pp 85-93.
18. Jackson AC (1997). Rabies. In: Viral Pathogenesis. Nathanson N, Ahmed R, Gonzalez-Scarano F, Griffin DE, Holmes K, Murphy FA, Robinson HL (eds). Lippincott-Raven, Philadelphia, pp 575-591.
19. Jackson AC, Rossiter JP (1997). Apoptosis plays an important role in experimental rabies virus infection. J Virol 71: 5603-5607.
20. Jackson AC, Wunner WH (1991). Detection of rabies virus genomic RNA and mRNA in mouse and human brains by using in situ hybridization. J Virol 65: 2839-2844.
21. Joly E, Mucke L, Oldstone MBA (1991). Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253: 1283-1285.
22. Kägi D, Hengartner H (1996). Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol 8: 472-477
23. Kucera P, Dolivo M, Coulon P, Flamand A (1985). Pathways of the early propagation of virulent and avirulent rabies strains from the eye to the brain. J Virol 55: 158-162.
24. Lafay F, Coulon P, Astic L, Saucier D, Riche D, Holley A, Flamand A (1991). Spread of the CVS strain of rabies virus and of the avirulent mutant Av01 along the olfactory pathways of the mouse after intranasal inoculation. Virology 183: 320-330.
25. Lampson LA, Fisher CA. (1984). Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon. Proc Natl Acad Sci USA 81: 6476-6480.
26. Larson JK, Wunner WH, Ertl HCJ (1992). Immune response to the nominal phosphoprotein of rabies virus. Virus Res 23: 73-88.
27. Marcovistz R, Leal EC, Matos DCD, Tsiang H (1994). Interferon production and immune response induction in apathogenic: rabies virus-infected mice. Acta Virol 38: 193-197.
28. Mifune K, Takeuchi E, Napiorkowski PA, Yamada A, Sakamoto K (1981). Essential role of T cells in the postexposure prophylaxis of rabies in mice. Microbiol Immunol 25: 895-904.
29. Miller A, Morse HC, Winkelstein J, Nathanson N (1978). The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. J Immunol 121: 321-326.
30. Mims CA (1960). Intracerebral injections and the growth of viruses in the mouse brain. Br J Exp Pathol 41: 52-59.
31. Moench TR, Griffin DE (1984). Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis. J Exp Med 159: 77-88.
32. Morimoto K, Ni Y-J, Kawai A (1992). Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic type G proteins of the rabies virus. Virology 189: 203-216.
33. Neumann H, Cavalie A, Jenne DE, Wekerle H (1995). Induction of MHC class I genes in neurons. Science 269: 549-552.
34. Oldstone MB (1997). How viruses escape from cytotoxic T lymphocytes: molecular parameters and players. Virology 234: 179-185.
35. Olsson T, Maehlen J, Love A, Klareskog L, Norrby E, Kristensson K (1988). Measles virus infection causes expression of class I and class II MHC antigens in rat brain. Ann NY Acad Sci 540: 486-487.
36. Pearce BD, Hobbs MV, McGraw TS, Buchmeier MJ (1994). Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J Virol 68: 5483-5495.
37. Seif I, Coulon P, Rollin PE, Flamand A (1985). Rabies virulence: Effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol 53: 926-935.
38. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russell PS (1985). Widespread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med 162: 1645-1664.
39. Smith JS (1981). Mouse model for abortive rabies infection of the central nervous system. Infect Immun 31: 297-308.
40. Torres-Anjel MJ, Montano-Hirose J, Cazabon EPI, Oakman JK, Wiktor TJ (1984). A new approach to the pathobiology of rabies virus as aided by immunoperoxidase staining. Am Assoc Vet Lab Diagn 27th Annual Proceed: 1-26.
41. Tyor WR, Johnson RT (1992). Immune responses and the central nervous system. In: Neuropathogenic Viruses and Immunity. Specter S, Bendinelli M and Friedman H (eds), Plenum Press, New York, pp 15-39.
42. Wekerle H, Linington C, Lassmann H, Meyermann R (1986). Cellular immune reactivity within the CNS. Trends Neurosci 9: 271-277.
43. Wiktor TJ (1973). Tissue culture methods. In: Laboratory Techniques in Rabies. Kaplan MM, Koprowski H (eds). World Health Organization, Geneva, pp 101-123.
44. Wiktor TJ (1978). Cell-mediated immunity and postexposure protection from rabies by inactivated vaccines of tissue culture origin. Dev Biol Stand 40: 255-264.
45. Wiktor TJ, Macfarlan RI, Reagan KJ, Dietzschold B, Curtis PJ, Wunner WH, Koprowski H (1984). Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proc Natl Acad Sci USA 81: 7194-7198.
46. Wong GH, Bartlett PF, Clark-Lewis I, McKimm-Breschkin JL, Schrader JW (1985). Interferon-gamma induces the expression of H-2 and Ia antigens on brain cells. J Neuroimmunol 7: 255-278.
47. Xiang ZQ, Ertl HC (1992). Transfer of maternal antibodies results in inhibition of specific immune responses in the offspring. Virus Res 24: 297-314.
48. Xiang ZQ, Knowles BB, Mccarrick JW, Ertl HCJ (1995). Immune effector mechanisms required for protection to rabies virus. Virology 214: 398-404.
49. Yang C, Jackson AC (1992). Basis of neurovirulence of avirulent rabies virus variant Av01 with stereotaxic brain inoculation in mice. J Gen Virol 73: 895-900.